Dawn Bir
Equibles does not estimate personal net worth.
About Dawn Bir
Dawn Bir is recorded as CEO at Geron Corp (GERN). Earlier roles on record: Board Member at Soleno Therapeutics Inc until May 18, 2026. Soleno Therapeutics Inc reported in an 8-K filed May 18, 2026 that Dawn Bir resigned as member of the Company's board of directors, effective May 18, 2026. Geron Corp is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Geron Corp includes Elizabeth G. O'Farrell (Chairman and Board Member), Michelle J. Robertson (CFO), Shanthakumar Tyavanagimatt (CTO) and 7 others.
“each of Anish Bhatnagar, M.D., Mark Hahn, Matthew Pauls, Birgitte Volck, Andrew Sinclair and Dawn Bir resigned from his or her respective positions as a member of the Company's board of directors and all committees thereof effective as of the Effective Time.”
Affiliation history
-
Current
-
Soleno Therapeutics Inc
Board Member
Proxy statement
Start not stated–2026-05-18
Company network
Soleno Therapeutics Inc
Biotechnology · Healthcare
Board Member
Leadership on record at Geron Corp
- Elizabeth G. O'Farrell Chairman, Board Member
- Michelle J. Robertson CFO
- Shanthakumar Tyavanagimatt CTO
- Constantine Chinoporos Board Member
- Dawn C. Bir Board Member
- Elizabeth G. O’Farrell Board Member
- Gaurav Aggarwal, M.D. Board Member
- Harout Semerjian Board Member
- John A. Scarlett, M.D. Board Member
- John F. McDonald Board Member